Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
Authors
Keywords
-
Journal
LANCET NEUROLOGY
Volume 22, Issue 2, Pages 127-136
Publisher
Elsevier BV
Online
2023-01-20
DOI
10.1016/s1474-4422(22)00495-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy
- (2021) Laura Rodríguez-Pascau et al. Science Translational Medicine
- Gait Difficulties and Postural Instability in Adrenoleukodystrophy
- (2021) Neha P. Godbole et al. Frontiers in Neurology
- Sensorimotor outcomes in adrenomyeloneuropathy show significant disease progression
- (2021) Jennifer L. Keller et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Clinical and radiographic course of arrested cerebral adrenoleukodystrophy
- (2020) Eric J. Mallack et al. NEUROLOGY
- Postural Body Sway as Surrogate Outcome for Myelopathy in Adrenoleukodystrophy
- (2020) Wouter J. C. van Ballegoij et al. Frontiers in Physiology
- PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia
- (2020) Laura Rodríguez-Pascau et al. NEUROBIOLOGY OF DISEASE
- Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy
- (2019) Nils Waldhüter et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The Landscape of Hematopoietic Stem Cell Transplant and Gene Therapy for X-Linked Adrenoleukodystrophy
- (2019) Eric J. Mallack et al. Current Treatment Options in Neurology
- Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation
- (2018) Gerald V. Raymond et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness
- (2018) Irene C Huffnagel et al. BRAIN
- European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene
- (2015) Manuel Haas et al. NEUROMUSCULAR DISORDERS
- Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy
- (2014) M. de Beer et al. NEUROLOGY
- Severity score system for progressive myelopathy: development and validation of a new clinical scale
- (2012) R.M. Castilhos et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
- (2012) Marc Engelen et al. Orphanet Journal of Rare Diseases
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- Development and Validation of the Short Form of a Urinary Quality of Life Questionnaire: SF-Qualiveen
- (2008) Véronique Bonniaud et al. JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started